Literature DB >> 7895184

Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells.

T Nagata1, K Kaho, S Nishikawa, H Shinohara, Y Wakano, H Ishida.   

Abstract

The effects of PGE2 on mineralized bone nodule formation were studied in fetal rat calvarial (RC) cells in vitro. Continuous exposure of RC cells to 3 x 10(-8) M PGE2 induced a twofold increase in mineralized bone nodule formation and a 1.5-fold increase in alkaline phosphatase (ALPase) activity without affecting RC cell growth. These stimulatory effects were evoked by concentrations of 3 x 10(-9)-3 x 10(-6) M PGE2 and the maximal effect was observed with 3 x 10(-8) M PGE2. The in vitro effects of PGE2 were evident when RC cells were exposed to it on days 8-14 and 8-21, which correspond to the post-confluent culture stage, but no effects were observed when the cells were exposed on days 1-7, the growth stage. The ALPase activity was also higher (1.2-1.4-fold) when 3 x 10(-8) M PGE2 was added during the post-confluent stage. In order to determine the effect of PGE2 during the mineralization phase of bone nodules in the presence of a large population of osteoprogenitor cells, RC cells were exposed to dexamethasone for 7 days before PGE2 was added during the post-confluent stage. A significantly higher percentage of nodules mineralized were observed with 3 x 10(-8)-3 x 10(-9) M PGE2 (1.6- and 1.4-fold, respectively), than in control cultures. Analysis of the mineral-related proteins by EDTA extraction of bone nodules followed by electrophoresis and Stains-All staining revealed an increased total amount of osteopontin extracted from the mineralized matrix after PGE2 treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7895184     DOI: 10.1007/bf00298559

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  29 in total

1.  The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system.

Authors:  J M KISSANE; E ROBINS
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

2.  The quantitative histochemistry of brain. II. Enzyme measurements.

Authors:  O H LOWRY; N R ROBERTS; M L WU; W S HIXON; E J CRAWFORD
Journal:  J Biol Chem       Date:  1954-03       Impact factor: 5.157

3.  Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.

Authors:  K Ueda; A Saito; H Nakano; M Aoshima; M Yokota; R Muraoka; T Iwaya
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

4.  Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation.

Authors:  D R Senger; C A Perruzzi; C F Gracey; A Papadopoulos; D G Tenen
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

5.  The role of 5'-methylthioadenosine on rat calvaria cell differentiation.

Authors:  S Kasahara; S Nishikawa; H Ishida; T Nagata; N Yamauchi; K Ohishi; Y Wakano; H Inoue
Journal:  Biochem Biophys Res Commun       Date:  1992-01-31       Impact factor: 3.575

6.  Characterization of the 1,25-(OH)2D3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvaria cells.

Authors:  H Ishida; C G Bellows; J E Aubin; J N Heersche
Journal:  Endocrinology       Date:  1993-01       Impact factor: 4.736

7.  The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation.

Authors:  W S Jee; K Ueno; Y P Deng; D M Woodbury
Journal:  Calcif Tissue Int       Date:  1985-03       Impact factor: 4.333

8.  Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta.

Authors:  T Kubota; Q Zhang; J L Wrana; R Ber; J E Aubin; W T Butler; J Sodek
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

9.  Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation in vitro.

Authors:  S Kasugai; T Nagata; J Sodek
Journal:  J Cell Physiol       Date:  1992-09       Impact factor: 6.384

10.  Effects of prostaglandins on rat calvarial bone-cell calcium.

Authors:  D Farr; W Pochal; M Brown; E Shapiro; N Weinfeld; R Dziak
Journal:  Arch Oral Biol       Date:  1984       Impact factor: 2.633

View more
  15 in total

1.  Treatment of segmental bone defects in rats by the stimulation of bone marrow osteo-progenitor cells with prostaglandin E2.

Authors:  A M Ozturk; E Cila; U Kanatli; I Isik; A Senkoylu; D Uzunok; E Piskin
Journal:  Int Orthop       Date:  2005-02-10       Impact factor: 3.075

2.  Effects of selective prostaglandins E2 receptor agonists on cultured calvarial murine osteoblastic cells.

Authors:  Cynthia B Alander; Lawrence G Raisz
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-10-20       Impact factor: 3.072

Review 3.  The osteocyte: an endocrine cell ... and more.

Authors:  Sarah L Dallas; Matthew Prideaux; Lynda F Bonewald
Journal:  Endocr Rev       Date:  2013-04-23       Impact factor: 19.871

4.  Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis.

Authors:  H Kadono; J Kido; M Kataoka; N Yamauchi; T Nagata
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 5.  Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer.

Authors:  Kalyani C Patil; Carolina Soekmadji
Journal:  Subcell Biochem       Date:  2021

6.  Effect of IL-15 and natural killer cells on osteoclasts and osteoblasts in a mouse coculture.

Authors:  Hiroaki Takeda; Takeshi Kikuchi; Kyoko Soboku; Iichiro Okabe; Hiroki Mizutani; Akio Mitani; Yuichi Ishihara; Toshihide Noguchi
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

7.  Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice.

Authors:  Sasanka Ramanadham; Kevin E Yarasheski; Matthew J Silva; Mary Wohltmann; Deborah Veis Novack; Blaine Christiansen; Xiaolin Tu; Sheng Zhang; Xiaoyong Lei; John Turk
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

8.  Prostaglandin promotion of osteocyte gap junction function through transcriptional regulation of connexin 43 by glycogen synthase kinase 3/beta-catenin signaling.

Authors:  Xuechun Xia; Nidhi Batra; Qian Shi; Lynda F Bonewald; Eugene Sprague; Jean X Jiang
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

9.  Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.

Authors:  Zheng Xu; Shilpa Choudhary; Yosuke Okada; Olga Voznesensky; Cynthia Alander; Lawrence Raisz; Carol Pilbeam
Journal:  Bone       Date:  2007-03-21       Impact factor: 4.398

10.  Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.

Authors:  Shilpa Choudhary; Hechang Huang; Lawrence Raisz; Carol Pilbeam
Journal:  Biochem Biophys Res Commun       Date:  2008-05-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.